Citation Impact
Citing Papers
Role of Preoperative Cessation of Smoking and Other Factors in Postoperative Pulmonary Complications: A Blinded Prospective Study of Coronary Artery Bypass Patients
1989
Chloramine-induced pneumonitis from mixing household cleaning agents.
1982
Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPD
2005
Reassessment of inflammation of airways in chronic bronchitis.
1985
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.
1979
Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma*
1991
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Reference values for pulmonary function tests of Japanese-American men aged 71 to 90 years.
1996
Determinants of progression in idiopathic pulmonary fibrosis.
1994
Upper Extremity Exercise Training in Chronic Obstructive Pulmonary Disease
1988
Premature discontinuation of patients: a potential bias in COPD clinical trials
2007
Eosinophilic Inflammation in Asthma
1990 Standout
Decline of FEV1 by age and smoking status: facts, figures, and fallacies
1997
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses
2003
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Spirometry Reference Values for Women and Men 65 to 85 Years of Age: Cardiovascular Health Study
1993
Short-term and Long-term Outcomes After Bilateral Lung Volume Reduction Surgery
2001
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2007
Reference Values for FEV 1 in Japanese-American Men from 45 to 68 Years of Age
1988
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
2000 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Exercise Standards for Testing and Training
2013 Standout
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Tissue Destruction by Neutrophils
1989 Standout
Effect of eicosapentaenoic acid in asthma
1988
House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding
1994
Standardisation of spirometry
2005 Standout
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
2008
Outcome of Subjects With Idiopathic Pulmonary Fibrosis Who Fail Corticosteroid Therapy
1993
Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis
2008
Primary Pulmonary Hypertension
1997 Standout
Single Lung Transplantation for Primary Pulmonary Hypertension
1990
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
The Influence of Cigarette Smoking on Lung Function in Patients with Idiopathic Pulmonary Fibrosis
1991
Survival in Patients with Primary Pulmonary Hypertension
1991 Standout
A Spirometry-Based Algorithm To Direct Lung Function Testing in the Pulmonary Function Laboratorya
2003
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
2009
References values for forced spirometry. Group of the European Community Respiratory Health Survey
1998
Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients
2008
Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis
2000
Long-term Outcome of Pediatric Sarcoidosis with Emphasis on Pulmonary Status
1992
Clinical Significance of an Isolated Reduction in Residual Volume
1987
Reference Values for Pulmonary Function in Asian Indians Living in the United States
2004
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease
1991
Membrane Diffusion and Capillary Blood Volume in Chronic Thromboembolic Pulmonary Hypertension
1996
Interpretative strategies for lung function tests
2005 Standout
Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: Short-term effects on exercise endurance and health status.
1990
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
The Relationship Between Alveolar Macrophage TNF, IL-1, and PGE2 Release, Alveolitis, and Disease Severity in Sarcoidosis
1993
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
2002
Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease.
1996
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Repeated Measures of FEV1 Over Six to Twelve Months: What Change is Abnormal?
2004
Outcome of the treatment for sarcoidosis.
1994
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 Standout
Erythromycin Suppresses Nuclear Factor-κB and Activator Protein-1 Activation in Human Bronchial Epithelial Cells
2000 StandoutNobel
Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation.
1997
Idiopathic Pulmonary Fibrosis
2001 Standout
Sarcoidosis
1997 Standout
The epidemiological importance of intraindividual changes in objective pulmonary responses
1987
Determinants of longitudinal changes in spirometric function among swine confinement operators and farmers.
1995
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
2004
Parenchymal Scarring Is Associated With Restrictive Spirometric Defects in Patients With Chronic Thromboembolic Pulmonary Hypertension
1996
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
1996
A Factor Analysis of Dyspnea Ratings, Respiratory Muscle Strength, and Lung Function in Patients with Chronic Obstructive Pulmonary Disease
1992
Methodology for generating continuous prediction equations for pulmonary function measures
1991
Evaluation of Clinical Methods for Rating Dyspnea
1988
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
1999 Standout
Idiopathic pulmonary fibrosis
2011 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65.
1995
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Physiological changes during symptom recovery from moderate exacerbations of COPD
2005
Right and Left Ventricular Dysfunction in Patients With Severe Pulmonary Disease
1998
Study on the initial velocity distribution of exhaled air from coughing and speaking
2012
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
A simple method to detect expiratory flow limitation during spontaneous breathing
1995
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Unexplained Exertional Limitation
2001
Airway Inflammation in Young Marijuana and Tobacco Smokers
1998
Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease
1999
Ethnic Differences in Pulmonary Function in Healthy Nonsmoking Asian-Americans and European-Americans
2000
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2011
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Effects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary Disease
2001
Spirometric Reference Values from a Sample of the General U.S. Population
1999 Standout
Prevalence of asthma in adults in Busselton, Western Australia.
1992
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
1987 Standout
Reversibility of pulmonary function abnormalities in smokers
1975
Bronchoalveolar Lavage
1984
Exercise and Physical Activity for Older Adults
2009 Standout
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.
1982
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension
2001
Errors in the measurement of total lung capacity in chronic obstructive lung disease.
1983
The changes in airways structure associated with reduced forced expiratory volume in one second
1989
Prognosis after recovery from adult respiratory distress syndrome.
1976
Concepts of normality applied to the measurement of lung function
1986
Ultrafine particle deposition in subjects with asthma.
2004
Lung volumes and forced ventilatory flows
1993 Standout
Responses to isoproterenol in a general population sample.
1978
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The Asthma Epidemic
2006 Standout
Partial and Complete Maximum Expiratory Flow-Volume Curves in Asthmatic Patients with Spontaneous Bronchospasm
1983
Volume Adjustment of Maximal Midexpiratory Flow
1980
Prognostic Role of Eosinophils in Pulmonary Fibrosis
1987
Diffusing capacity predicts morbidity and mortality after pulmonary resection
1988
The Measurement of Dyspnea
1984
A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema
2003 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Airways Obstruction and the Risk for Lung Cancer
1987
A Comparison of Spirometric Values with Subjects in Standing and Sitting Positions
1976
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years
1983 Standout
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator
2005
A review of the racial differences in the lung function of normal Caucasian, Chinese and Indian subjects
1991
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Functional correlates of lung involvement in Wegener's granulomatosis
1980
Partial and Maximal Expiratory Flow-Volume Curves in Normal and Asthmatic Subjects Before and After Inhalation of Metaproterenol
1985
Changes in Measured Spirometric Indices
1981
Evaluation of the dead space/tidal volume ratio in patients with chronic congestive heart failure
1995
Airborne transmission of respiratory viruses
2021 StandoutScience
Primary Pulmonary Hypertension
1987 Standout
Ventilatory parameters in healthy nonsmoking adults of Adriatic islands (Yugoslavia)
1991
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Reference values and prediction equations for normal lung function in a non-smoking white urban population.
1991
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
1983
Continuous longitudinal regression equations for pulmonary function measures
1992
Works of Arthur Koski being referenced
Fifteen-year Interval Spirometric Evaluation of the Oregon Predictive Equations
1988
Spirometric Standards for Healthy Nonsmoking Adults
1971
Spirometric standards for healthy nonsmoking adults.
1971